Imagine having a research idea that has the potential to change and save lives – then, imagine having the seed funding to begin your work.
The London Regional Cancer Program (LRCP)* Catalyst Grants Program is the only program of its kind in London that is dedicated to cancer research, and it is 100-per-cent donor funded. This important program provides seed or “leverage” funding (currently up to $25,000 per application) to enable cancer researchers to begin or continue their work, and to secure larger grants from external sources.
It’s estimated that every $1 in funding provided through the Catalyst Grants Program generates $5 in further research funding. Support from the program allows LRCP clinicians and scientists to be quick in pursuing exciting ideas, and is the catalyst that drives this research forward. Without donor dollars, this program simply would not exist.
We graciously acknowledge the generous support of the Breast Cancer Society of Canada, Mr. Keith Samitt, The London Run for Ovarian Cancer, Lexus of London Golf Classic, Blood, Sweat and Spin, The Lions Clubs of Zone 3, District A-1 and our other generous organizations and supporters of cancer research in London and the greater Southwestern Ontario region.
Dr. Alison Allan
Relationship between pEMT status, epigenetic modifications, and migratory mode in prostate cancer
Amount Funded: $25,000 (Translational Prostate Cancer Research focus)
Dr. Glenn Bauman, Co-Applicants: Drs. Aaron Ward, Madeleine Moussa, Rohann Correa
Assessment of novel radio-genomic correlations in multi-focal prostate cancer
Amount Funded: $25,000 (Translational Prostate Cancer Research focus)
Dr. Ricardo Fernandes, Co-Applicant: Dr. Saman Maleki
Preventing immune-related adverse events in renal cell carcinoma patients treated with combination immunotherapy using fecal microbiota transplantation
Amount Funded: $24,195 (Keith Samitt Translational Research Grant)
Dr. Ana Lohmann
Concordance between Liquid and Tissue Biopsy in Newly Diagnosed Metastatic Breast Cancer
Amount Funded: $25,000 (Translational Breast Cancer Research focus)
Dr. Saman Maleki
The role of IL12 and IL27 on inducing CD39 expression on tumour-specific CD8+ T-cells
Amount Funded: $23,854 (Keith Samitt Translational Research Grant)
Dr. Armen Parsyan, Co-Applicant: Dr. Alison Allan
Anticancer Effects of Radiation Therapy Combined with PLK4 Inhibitor CFI-400945 in Breast Cancer
Amount Funded: $25,000 (Translational Breast Cancer Research focus)
Dr. Silvia Penuela, Co-Applicants: Drs. John Ronald, Matthew Hebb
Pannexin 1 channels in glioblastoma multiforme
Amount Funded: $25,000 (Keith Samitt Translational Research Grant)
Dr. Trevor Shepherd, Co-Applicant: Matthew Borrelli
Characterization of mitochondrial function and mitophagy during bioenergetic stress in ovarian cancer
Amount Funded: $21,500 (Translational Ovarian Cancer Research focus)
Dr. Eva Turley
RHAMM peptide mimetics in multiple myeloma
Amount Funded: $25,000 (Translational Myeloma Cancer Research focus)
Dr. Anargyros Xenocostas , Co-Applicants: Drs. Alejandro Lazo-Langner, Shun-Cheng Li
Dynamic Epigenomic and Proteomic Profiling in Patients with Myelodysplastic Syndromes: A Pilot Study
Amount Funded $22,500 (Translational Leukemia Cancer Research focus)
Congratulations and well done!
* Renamed the Verspeeten Family Cancer Centre in 2024